Literature DB >> 27669102

Communicating Delicately: Introducing the Need to Make a Decision About the Use of Life-Sustaining Treatment.

Kristen E Pecanac1.   

Abstract

The purpose of this study was to explore how clinicians introduce the need to make a decision about the use of life-sustaining treatment and how surrogates respond to these introductions during family conferences in the intensive care unit. This article focuses on the use of the perspective-display sequence as a way to introduce the decision-making conversation. In the family conferences, the perspective-display sequence involved (a) the clinician's perspective-display invitation of the surrogates' assessment of the patient's wishes, (b) the surrogates' reply or assessment, and (c) the clinician's decision proposal, which often incorporates the surrogates' assessment. Asking about the patient's wishes is a delicate way to ease into the decision-making conversation. By using the perspective-display sequence, clinicians are also participating in shared decision making; their decision proposal is co-constructed with surrogates' understanding of the patient's wishes regarding the treatment.

Entities:  

Mesh:

Year:  2016        PMID: 27669102     DOI: 10.1080/10410236.2016.1217455

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  3 in total

1.  Communication between healthcare professionals and relatives of patients approaching the end-of-life: A systematic review of qualitative evidence.

Authors:  Rebecca J Anderson; Steven Bloch; Megan Armstrong; Patrick C Stone; Joseph Ts Low
Journal:  Palliat Med       Date:  2019-06-11       Impact factor: 4.762

2.  Communication Strategies in a Code Status Conversation.

Authors:  Kristen E Pecanac; Eric Yanke
Journal:  ATS Sch       Date:  2020-06-30

Review 3.  Communicating with patients and families about illness progression and end of life: a review of studies using direct observation of clinical practice.

Authors:  Stuart Ekberg; Ruth Parry; Victoria Land; Katie Ekberg; Marco Pino; Charles Antaki; Laura Jenkins; Becky Whittaker
Journal:  BMC Palliat Care       Date:  2021-12-08       Impact factor: 3.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.